Viewing StudyNCT03613168



Ignite Creation Date: 2024-05-06 @ 11:51 AM
Last Modification Date: 2024-10-26 @ 12:50 PM
Study NCT ID: NCT03613168
Status: COMPLETED
Last Update Posted: 2021-01-05
First Post: 2018-07-28

Brief Title: Trastuzumab in HER2-positive Biliary Tract Cancer
Sponsor: Changhoon Yoo
Organization: Asan Medical Center

Conditions & Keywords Data

Conditions:
Name
HER-2 Gene Amplification
Cholangiocarcinoma
Biliary Tract Cancer
HER-2 Protein Overexpression
Keywords:
Name View
Trastuzumab View
Cholangiocarcinoma View
Biliary Tract Cancer View